# US 2006/0051390 A1 · Medical devices having self-forming rate-controlling barrier for drug release

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0051390 A1
- Document ID: US20060051390A1
- Status: Published application
- Kind: A1
- Application number: 10/934,844
- Filed: 2004-09-03
- Published: 2006-03-09
- Earliest claimed: 2004-09-03
- Inventors: Marlene Schwarz
- Web page: https://patentgrep.com/patent/US20060051390A1

## CPC

- A61L 29/041: {obtained by reactions only involving carbon-to-carbon unsaturated bonds}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 31/048: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence)}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 2300/604: Biodegradation
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Therapeutic-agent-releasing medical devices are provided herein, which contain a rate controlling release region that includes a biodisintegrable agent and a biostable low glass transition temperature polymer. Upon contact (e.g., implantation or insertion) of the medical device with a subject, at least the surface of the release region becomes depleted of the biodisintegrable agent, and the low glass transition temperature polymer migrates to occupy at least a portion of the volume that is created by the departure of the biodisintegrable agent, thereby forming a barrier layer for therapeutic agent remaining within the device.

## Claims

### Claim 1

A therapeutic-agent-releasing medical device comprising a rate controlling release region that comprises a biodisintegrable agent and a biostable low glass transition temperature polymer, wherein upon contact of said medical device with a subject, the release region becomes depleted with respect to the biodisintegrable agent, and the low glass transition temperature polymer migrates to occupy at least a portion of the volume that is created by the departure of the biodisintegrable agent, thereby forming a barrier layer for therapeutic agent remaining within the device.

### Claim 2 (depends on 1)

The medical device of claim 1, wherein said release region comprises a polymeric biodisintegrable agent.

### Claim 3 (depends on 1)

The medical device of claim 1, wherein said release region comprises a water-soluble polymeric biodisintegrable agent.

### Claim 4 (depends on 1)

The medical device of claim 1, wherein said release region comprises a polymeric biodisintegrable agent selected from soluble polysaccharide-containing polymers, soluble protein-containing polymers, poly(alpha-hydroxy acids), polyacrylamides, polyalkylene oxides, polyanhydrides polyvinylpyrrolidone, alginic acid and its salts, hyaluronic acid and its salts, carboxyvinyl polymers and their salts, and polyacrylic acid and its salts.

### Claim 5 (depends on 1)

The medical device of claim 1, wherein said release region comprises a non-polymeric biodisintegrable agent.

### Claim 6 (depends on 1)

The medical device of claim 1, wherein said release region comprises a non-polymeric biodisintegrable agent selected from a sugar or a salt.

### Claim 7 (depends on 1)

The medical device of claim 1, wherein said biodisintegrable agent is provided in the form of biodisintegrable particles dispersed within said release region.

### Claim 8 (depends on 1)

The medical device of claim 1, wherein said release region comprises a plurality of biodisintegrable agents.

### Claim 9 (depends on 1)

The medical device of claim 1, wherein said low glass transition temperature polymer is selected from low glass transition temperature polyurethanes, low glass transition temperature silicones, low glass transition temperature acrylates, and low glass transition temperature polyolefins.

### Claim 10 (depends on 1)

The medical device of claim 1, wherein said release region comprises a plurality of low glass transition temperature polymers.

### Claim 11 (depends on 1)

The medical device of claim 1, wherein said release region is disposed over an underlying region that comprises said therapeutic agent.

### Claim 12 (depends on 11)

The medical device of claim 11, wherein said underlying region is in the form of a layer.

### Claim 13 (depends on 11)

The medical device of claim 11, wherein said underlying region further comprises a polymer.

### Claim 14 (depends on 1)

The medical device of claim 1, wherein said release region comprises said therapeutic agent.

### Claim 15 (depends on 14)

The medical device of claim 14, wherein said release region comprises a plurality of therapeutic agents.

### Claim 16 (depends on 14)

The medical device of claim 14, wherein said biodisintegrable agent corresponds to said therapeutic agent.

### Claim 17 (depends on 14)

The medical device of claim 14, wherein said release region comprises a non-therapeutic biodisintegrable agent and said therapeutic agent.

### Claim 18 (depends on 14)

The medical device of claim 14, wherein said release region is disposed over an underlying layer that comprises additional therapeutic agent, and wherein said additional therapeutic in said underlying agent is different from said therapeutic agent in said release region.

### Claim 19 (depends on 14)

The medical device of claim 14, wherein said release region is disposed over an underlying layer that comprises additional therapeutic agent, and wherein said additional therapeutic in said underlying agent is the same as said therapeutic agent in said release region.

### Claim 20 (depends on 1)

The medical device of claim 1, wherein said medical device comprises a plurality of release regions.

### Claim 21 (depends on 1)

The medical device of claim 1, wherein said release region is in the form of a layer that covers all or a part of an underlying substrate.

### Claim 22 (depends on 1)

The medical device of claim 1, wherein said medical device is an implantable or insertable medical device.

### Claim 23 (depends on 22)

The medical device of claim 22, wherein said implantable or insertable medical device is selected from a catheter, a guide wire, a balloon, a filter, a stent, a stent graft, a vascular graft, a vascular patch and a shunt.

### Claim 24 (depends on 22)

The medical device of claim 22, wherein said implantable or insertable medical device is adapted for implantation or insertion into the coronary vasculature, peripheral vascular system, esophagus, trachea, colon, biliary tract, urinary tract, prostate or brain.

### Claim 25 (depends on 1)

The medical device of claim 1, wherein said therapeutic agent is selected from one or more of the group consisting of anti-thrombotic agents, anti-proliferative agents, anti-inflammatory agents, anti-migratory agents, agents affecting extracellular matrix production and organization, antineoplastic agents, anti-mitotic agents, anesthetic agents, anti-coagulants, vascular cell growth promoters, vascular cell growth inhibitors, cholesterol-lowering agents, vasodilating agents, and agents that interfere with endogenous vasoactive mechanisms.
